Product correctly added to cart.

discount label
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethanamine
View 3D

Biosynth logo

2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethanamine

CAS: 751476-91-2

Ref. 3D-FT90054

1gTo inquire
500mgTo inquire
Estimated delivery in United States, on Friday 29 Nov 2024

Product Information

Name:
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethanamine
Description:

2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethanamine is a synthetic compound that has shown promising results in the treatment of prostatic hyperplasia. It works by highlighting the condensation process and inhibiting the α1-adrenoceptor, which is responsible for the growth of prostate cells. This compound has been extensively researched and is classified under Research Chemicals. It undergoes etherification and diazotization reactions to produce its active form. 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethanamine acts as an antagonist to silodosin, another medication used for prostatic hyperplasia. Its unique properties make it an effective option for accessing relief from this condition through acidolysis.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
235.2 g/mol
Formula:
C10H12F3NO2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FT90054 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethanamine

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".